MeSH Browser

MeSH Heading: Canagliflozin
Tree Number(s): D02.886.778.075; D03.383.903.075; D09.408.348.113
Unique ID: D000068896
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068896
Scope Note: A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.
Entry Term(s): 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973; Canagliflozin Hemihydrate; Canagliflozin, Anhydrous; Invokana
Pharm Action: Sodium-Glucose Transporter 2 Inhibitors
Related Numbers: 6S49DGR869; 928672-86-0
Public MeSH Note: 2016; CANAGLIFLOZIN was indexed under GLUCOSIDES and THIOPHENES 2014-2015
History Note: 2016 (2014)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2018/02/28

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Canagliflozin MeSH Descriptor Data 2024